Literature DB >> 10643894

Continuous blockade of brain mineralocorticoid receptors impairs spatial learning in rats.

J L Yau1, J Noble, J R Seckl.   

Abstract

Hippocampal mineralocorticoid receptors (MR) are proposed to mediate facilitation of cognition in the short-term. The acute central blockade of MR increases plasma corticosterone levels which itself can affect cognition thus complicating the interpretation of such studies. We therefore investigated the effects of chronic continuous central MR antagonism by spironolactone infused intracerebroventricularly (i.c.v.) (100 ng/h) via Alzet minipumps for 12 days. Rats given chronic i.c.v. infusion of spironolactone spent significantly less time (20% decrease, P < 0.05) within the platform quadrant during the watermaze probe test. Neither hippocampal MR nor glucocorticoid receptor mRNA expression were affected by spironolactone. Morning plasma corticosterone levels and adrenal and thymic weights were unchanged. Chronic central MR antagonism impairs spatial memory in the watermaze independent of changes in receptors or circulating glucocorticoid levels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10643894     DOI: 10.1016/s0304-3940(99)00858-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  21 in total

1.  Loss of the limbic mineralocorticoid receptor impairs behavioral plasticity.

Authors:  Stefan Berger; David P Wolfer; Oliver Selbach; Heike Alter; Gitta Erdmann; Holger M Reichardt; Aisa N Chepkova; Hans Welzl; Helmut L Haas; Hans-Peter Lipp; Günther Schütz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-20       Impact factor: 11.205

2.  Administration of a selective glucocorticoid antagonist attenuates electroconvulsive shock-induced retrograde amnesia.

Authors:  Chittaranjan Andrade; Shahid Ahmad Shaikh; Lakshmy Narayan; Christine Blasey; Joseph Belanoff
Journal:  J Neural Transm (Vienna)       Date:  2011-09-16       Impact factor: 3.575

Review 3.  The multifaceted mineralocorticoid receptor.

Authors:  Elise Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

4.  Role of corticosterone in trace and delay conditioned fear-potentiated startle in rats.

Authors:  Michael A Burman; Kathryn L Hamilton; Jonathan C Gewirtz
Journal:  Behav Neurosci       Date:  2010-04       Impact factor: 1.912

Review 5.  Third-generation Mineralocorticoid Receptor Antagonists: Why Do We Need a Fourth?

Authors:  Elise P Gomez-Sanchez
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

6.  Spatial ability is impaired and hippocampal mineralocorticoid receptor mRNA expression reduced in zebra finches (Taeniopygia guttata) selected for acute high corticosterone response to stress.

Authors:  Zoë G Hodgson; Simone L Meddle; Mark L Roberts; Katherine L Buchanan; Matthew R Evans; Reinhold Metzdorf; Manfred Gahr; Susan D Healy
Journal:  Proc Biol Sci       Date:  2007-01-22       Impact factor: 5.349

7.  11beta-hydroxysteroid dehydrogenase type 1 deficiency prevents memory deficits with aging by switching from glucocorticoid receptor to mineralocorticoid receptor-mediated cognitive control.

Authors:  Joyce L W Yau; June Noble; Jonathan R Seckl
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

8.  THE RELATIONSHIP BETWEEN ACUTE GLUCOCORTICOID LEVELS AND HIPPOCAMPAL FUNCTION DEPENDS UPON TASK AVERSIVENESS AND MEMORY PROCESSING STAGE.

Authors:  Cheryl D Conrad
Journal:  Nonlinearity Biol Toxicol Med       Date:  2005

9.  Glucocorticoid mechanisms may contribute to ECT-induced retrograde amnesia.

Authors:  Nandakumar Nagaraja; Chittaranjan Andrade; Suresh Sudha; Nagendra Madan Singh; J Suresh Chandra; B V Venkataraman
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

10.  Learning deficits in C57BL/6J mice following perinatal arsenic exposure: consequence of lower corticosterone receptor levels?

Authors:  Ebany J Martinez-Finley; Abdul-Mehdi S Ali; Andrea M Allan
Journal:  Pharmacol Biochem Behav       Date:  2009-09-13       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.